Future Journal of Pharmaceutical Sciences

Table 10 Thermal degradation peak results

From: Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach

	Sample	Retention time	Area	Height	Tailing	Plate count	Purity1 angle	Purity1 threshold
01	Peak1	0.067
02	Triamterene	0.918	802,817	305,133	1.61	2408.53	0.212	0.379
03		1.158	1266	637	2.61	7046.27
04	Peak3	1.285
05		1.385	25,485	7798	1.15	3842.44	1.298	1.706
06	Peak4	1.542	30,086	8623		3901.05
07		1.598	6812	3162		1494.43
08	HCTZ	1.736	922,762	231,601	1.32	4218.36	0.176	0.278
09	Peak6	2.516
10		3.342	159	317	1.00	305,940.06
11	Peak7	4.033	105	209	1.00	419,284.37
12	Peak8	5.817

Back to article page